期刊文献+

中老年高血压维生素D水平分析 被引量:2

Vitamin D Levels in Middle-Aged and Elderly Patients with Hypertension
下载PDF
导出
摘要 目的测定中老年高血压患者的维生素D水平,为开展健康教育,预防治疗中老年高血压病提供依据。方法选择中老年高血压患者110例(高血压组)和血压正常者50例(对照组)为研究对象,按其高血压程度分为高血压1级组(30例)、高血压2组(40例)和高血压3级组(40例)。采用酶联免疫法测定各组25-羟基维生素D水平。结果高血压1级组、高血压2级组、高血压3级组的25-羟基维生素D水平无明显差别,3组比较差异无统计学意义(P>0.05);高血压组25-羟基维生素D水平较对照组明显降低,2组比较差异有统计学意义(P<0.05)。结论中老年高血压患者维生素D水平的高低与高血压的高低无关,但普遍缺乏维生素D,建议要适当补充维生素D以预防治疗中老年高血压病。 Objective To determine the levels of vitamin D in middle-aged and elderly patients with hypertension, and to provide a basis for carrying out health education and preventing and treating hypertension. Methods In 110 patients with hypertension(hypertension group) and 50 cases of normal blood pressure(Group) as the research object,according to the degree of hypertension were divided into grade 1 hypertension group (30 cases),grade 2 hypertension group (40 cases) and stage 3 hypertension group(40 cases).25-hydroxy vitamin Dlevels were measured by enzyme linked immunosorbent assay. Results There were no significant differences in 25-hydroxyvitamin D levels among grade 1 hyperte-nsion group, grade 2 hypertension group and grade 3 hypertension group (P〉0.05). Compared with control group, 25-hydroxyvitamin D levels significantly decreased in hypertension group (P〈0.05). Conclusion There is no correlation between the level of vitamin D and the degree of hypertension in middle-aged and elderly patients with hypertension. However, these patients generally lack vitamin D, which should be appropriately supplied to prevent and treat hypertension in middle-aged and elderly patients.
出处 《实用临床医学(江西)》 CAS 2014年第5期18-19,21,共3页 Practical Clinical Medicine
关键词 高血压 维生素D 水平 中老年 hypertension vitamin D level middle-aged and elderly patients
  • 相关文献

参考文献1

二级参考文献11

  • 1Zittermann A,Schleithoff SS,Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective[J]. Br J Nutr,2005,94 (4) :483--492.
  • 2Giovannucci E, Liu Y, Hollis BW,et al.25-Hydroxyvitamin D and risk of myocardial infarction in men:a prospective study[J]. Arch Intern Med, 2008,168( 11 ) : 1174-1180.
  • 3Dobnig H,Pilz S,Schamagl H,et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality [J]. Arch Intern Meal,2008,168 (12) : 1340-1349.
  • 4Forman JP,Giovannucci E,Holmes MD,et al. Plasma 25-hydroxy vitamin D levels and risk of incident hypertension [J]. Hypertension 2007,49(5) : 1063-1069.
  • 5Knekt P, Laaksonen M, Mattila C, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes[J]. Epidemiology,2008,19 (5):666-671.
  • 6Melamed ML,Muntner P,Michos ED,et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease:results from NHANES 2001 to 2004[J]. Arterioscler Thromb Vasc Biol,2008,28 (6) : 1179-1185.
  • 7Wang TJ,Pencina MJ,Booth SL,et al. Vitamin D deficiency and risk of cardiovascular disease[J]. Circulation,2008,117 (4): 503-511.
  • 8Melamed ML,Michos ED,Post W,et al. 25-Hydroxyvitamin D levels and the risk of mortality in the general population[J]. Arch Intern Med,2008,168(15) : 1629-1637.
  • 9Holick MF. Vitamin D deficiency[J]. N Engl J Med,2007,357(3): 266-281.
  • 10Mattila C,Knekt P,Mannist S,et al. Serum 25-hydroxyvi-tamin D concentration and subsequent risk of type 2 diabetes [J]. Diabetes Care, 2007,30(10) : 2569-2570.

共引文献1

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部